289 / 671
Radiotherapy for SVCS II
• SBRT – promising but so far no proven benefit, for highly selected patients
in better condition
(Mc Kenzie Rep Pract Radiot Oncol 2013)
• Always think about the
future of patient and doses
– some patients may be
further treated with RT!
• BT- HDR, following stenting or
as a salvage
after EBRT for intraluminal
recurrence
• Addition endobronchial BT to EBRT – no benefit
• Concurrent chemotherapy – no added benefit
JK 22/49